Literature DB >> 15441029

Field tests of molluscacides against Australorbis glabratus in endemic areas of schistosomiasis in Puerto Rico.

E G BERRY, M O NOLAN, J OLIVER GONZALEZ.   

Abstract

Entities:  

Keywords:  SCHISTOSOMIASIS

Mesh:

Substances:

Year:  1950        PMID: 15441029

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0094-6214            Impact factor:   2.792


× No keyword cloud information.
  9 in total

1.  Use of molluscicides for bilharziasis control in Puerto Rico.

Authors:  F F FERGUSON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

2.  Bilharziasis control by application of molluscicides; a review of its present status.

Authors:  E PAULINI
Journal:  Bull World Health Organ       Date:  1958       Impact factor: 9.408

3.  [Bilharziosis in the Belgian Congo and in Ruanda-Urundi].

Authors:  J GILLET; J WOLFS
Journal:  Bull World Health Organ       Date:  1954       Impact factor: 9.408

4.  The toxicity of some related halogenated derivatives of phenol.

Authors:  E F STOHLMAN
Journal:  Public Health Rep       Date:  1951-10-12       Impact factor: 2.792

5.  Experiments in the control of schistosomiasis in Brazil.

Authors:  W H WRIGHT; C G DOBROVOLNY
Journal:  Public Health Rep       Date:  1953-12       Impact factor: 2.792

6.  Determination of sodium and copper pentachlorophenates in dilute aqueous solutions.

Authors:  W T HASKINS
Journal:  Public Health Rep       Date:  1951-08-17       Impact factor: 2.792

7.  Hospital beds in the United States, 1950.

Authors:  J W CRONIN; L S REED; A M BANEY
Journal:  Public Health Rep       Date:  1950-11-10       Impact factor: 2.792

8.  [Copper molluscacides in the prophylaxis of bilharziasis].

Authors:  R Deschiens; H Floch; Y Le Corroller
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

9.  Tri-iodophenol (Triophyll) in the treatment of bladder and urethral infections.

Authors:  C E WINTER; R W BARNES; B Y WAT; J C ELGIN; J B LYONS
Journal:  J Natl Med Assoc       Date:  1956-07       Impact factor: 1.798

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.